placebo showed a decline in renal function reduced in a highly significant way in the arm treated with ACEI, especially if proteinuria >3 g/day was present. 7 Similar results were obtained about sartans, for example, in the Irbesartan Diabetic Nephropathy Trial (IDNT) where irbesartan was compared with amlodipine.
← all excerpts
Preserving renal function: gliflozins, GLP1 agonists, and antialdosterones.
1
—
—